androstenedione has been researched along with atamestane in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (32.43) | 18.7374 |
1990's | 19 (51.35) | 18.2507 |
2000's | 6 (16.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henderson, D | 1 |
di Salle, E; Giudici, D; Ornati, G; Panzeri, A; Zaccheo, T | 1 |
Khan, SA; Nieschlag, E; Simoni, M | 1 |
Briatico, G; di Salle, E; Giudici, D; Ornati, G | 1 |
el Etreby, MF; Habenicht, UF; Henderson, D; Kerb, U; Nishino, Y | 1 |
el Etreby, MF; Habenicht, UF | 4 |
Aumüller, G; el Etreby, MF; Habenicht, UF | 1 |
el Etreby, MF; Habenicht, UF; Neumann, F; Schwarz, K | 1 |
el Etreby, MF; Ghoniem, G; Habenicht, UF; Lewis, R; Roberts, J | 1 |
Briatico, G; di Salle, E; Giudici, D; Ornati, G; Zaccheo, T | 1 |
el Etreby, MF; Michna, H; Nishino, Y; Schneider, MR | 1 |
Habenicht, UF; Hochstrate, H; Krieg, M; Tunn, S | 1 |
el Etreby, MF; Schröder, H; Ziegler, M | 1 |
Henderson, D; Kerb, U; Norbisrath, G | 1 |
Goldschmidt, AJ; Tunn, UW | 1 |
Andriole, GL; Keetch, DW | 1 |
el Etreby, MF; Gormley, GJ; Imperato-McGinley, JL; Oesterling, JE; Roehrborn, CG; Schröder, FH; Tunn, UW | 1 |
Gingell, JC; Knönagel, H; Kurth, KH; Tunn, UW | 1 |
Ekman, P | 1 |
Bartsch, G; el Etreby, MF; Habenicht, UF; Schröder, FH; Schweikert, HU; Senge, T; Tunn, UW | 1 |
el Etreby, MF | 1 |
Arnold, J; Blom, JH; Ennemoser, O; Habenicht, UF; Horniger, W; Schröder, FH; Schulze, H; Schweikert, HU; Senge, T; Tunn, UW | 1 |
Hakky, SI; Hudson, PB; Lombardo, ME | 1 |
Höffken, K | 1 |
Bono, AV; Eickenberg, HU; Fletcher, MS; Fourcade, RO; Radlmaier, A; Reis Santos, JM; van Aubel, OG | 1 |
Andreani, CL; Caruso, A; Cento, R; Lanzone, A; Lazzarin, N; Mancuso, S; Pierro, E | 1 |
Harada, N; Hatano, O | 1 |
Bidlingmaier, F; Hans, VH; Heidrich, DD; Klingmüller, D; Schramm, J; Steckelbroeck, S; Stoffel-Wagner, B | 1 |
Grobbee, DE; Lamberts, SW; Muller, M; van den Beld, AW; van der Schouw, YT | 1 |
Cheung, AM; Goss, PE; Hu, H; Qi, S | 1 |
Blanchett, D; Demers, L; Goss, PE; Langecker, P; Ohorodnik, S; Santen, RJ; Settlage, J; Wang, S | 1 |
Brodie, A; Goloubeva, O; Macedo, L; Sabnis, GJ; Schayowitz, A; Zhu, Y | 1 |
Blanchett, D; Bondarenko, IN; Goss, P; Langecker, P; Manikhas, GN; Miller, WH; Pendergrass, KB | 1 |
Goss, PE; Hu, H; Qi, S | 1 |
5 review(s) available for androstenedione and atamestane
Article | Year |
---|---|
The function and the role of aromatase inhibitors in the treatment of BPH.
Topics: Androgens; Androstenedione; Animals; Aromatase Inhibitors; Clinical Trials as Topic; Disease Models, Animal; Estrogens; Flutamide; Humans; Macaca fascicularis; Male; Prostate; Prostatic Hyperplasia | 1994 |
Endocrine therapies for BPH: scientific rationale, clinical results, and patient selection.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Androstenedione; Animals; Aromatase Inhibitors; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Models, Biological; Patient Selection; Prostate; Prostatic Hyperplasia | 1994 |
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Humans; Male; Prostatic Hyperplasia; Tamoxifen | 1993 |
Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
Topics: Androgens; Androstenedione; Animals; Aromatase Inhibitors; Dogs; Estrogens; Female; Humans; Male; Ovary; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estrogen | 1993 |
Experience with aromatase inhibitors in the treatment of advanced breast cancer.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Forecasting; Humans | 1993 |
6 trial(s) available for androstenedione and atamestane
Article | Year |
---|---|
Placebo controlled double-blind study to test the efficacy of the aromatase inhibitor atamestane in patients with benign prostatic hyperplasia not requiring operation. The Schering 90.062 Study Group.
Topics: Aged; Androstenedione; Aromatase Inhibitors; Double-Blind Method; Humans; Male; Prospective Studies; Prostatic Hyperplasia | 1995 |
Endocrine therapy for benign prostatic hyperplasia in the 90's.
Topics: Androstenedione; Aromatase Inhibitors; Controlled Clinical Trials as Topic; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Placebos; Prostatic Hyperplasia; Testolactone | 1995 |
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group.
Topics: Aged; Androgens; Androstenedione; Aromatase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrone; Humans; Male; Middle Aged; Placebos; Prostatic Hyperplasia | 1996 |
Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Androstenedione; Bone Density; Dehydroepiandrosterone; Double-Blind Method; Frail Elderly; Hormone Replacement Therapy; Humans; Male; Testosterone | 2006 |
Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy.
Topics: Androstenedione; Aromatase Inhibitors; Biological Assay; Breast Neoplasms; Estradiol; Female; Gas Chromatography-Mass Spectrometry; Humans; Letrozole; Nitriles; Placebos; Postmenopause; Radioimmunoassay; Sensitivity and Specificity; Tandem Mass Spectrometry; Triazoles | 2007 |
Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast cancer.
Topics: Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Steroid; Toremifene; Triazoles | 2007 |
26 other study(ies) available for androstenedione and atamestane
Article | Year |
---|---|
Estrogens and benign prostatic hyperplasia: rationale for therapy with aromatase inhibitors.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Estrogens; Humans; Male; Prostatic Hyperplasia | 1991 |
Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Cell Division; Dose-Response Relationship, Drug; Endocrine Glands; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Organ Size; Ovariectomy; Pargyline; Prolactin; Rats | 1991 |
Serum bioactive follicle-stimulating hormone-like activity in human pregnancy is a methodological artifact.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Artifacts; Biological Assay; Cells, Cultured; Estradiol; Female; Follicle Stimulating Hormone; Humans; Kinetics; Male; Pregnancy; Rats; Rats, Inbred Strains; Sertoli Cells | 1991 |
Novel irreversible aromatase inhibitors.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Animals; Aromatase Inhibitors; Female; Gonadotropins, Equine; Humans; In Vitro Techniques; Kinetics; Microsomes; Ovary; Pargyline; Placenta; Rats; Rats, Inbred Strains | 1990 |
Aromatase inhibitors and benign prostatic hyperplasia.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Gonadotropins, Equine; Humans; Kinetics; Male; Prostatic Hyperplasia; Species Specificity | 1986 |
Synergic inhibitory effects of the aromatase inhibitor 1-methyl-androsta-1, 4-diene-3, 17-dione and the antiandrogen cyproterone acetate on androstenedione-induced hyperplastic effects in the prostates of castrated dogs.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Castration; Cyproterone; Cyproterone Acetate; Dogs; Drug Synergism; Drug Therapy, Combination; Male; Prostate; Prostatic Hyperplasia; Time Factors | 1987 |
Pharmacologically induced ultrastructural and immunohistochemical changes in the prostate of the castrated dog.
Topics: Acid Phosphatase; Androstenedione; Animals; Aromatase Inhibitors; Castration; Cyproterone; Dogs; Immunohistochemistry; Keratins; Male; Prostate; Vimentin | 1987 |
Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Disease Models, Animal; Estradiol; Macaca fascicularis; Male; Organ Size; Prostate; Prostatic Hyperplasia | 1987 |
Selective inhibition of androstenedione-induced prostate growth in intact beagle dogs by a combined treatment with the antiandrogen cyproterone acetate and the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione (1-methyl-ADD).
Topics: Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Cyproterone; Cyproterone Acetate; Dogs; Epididymis; Luteinizing Hormone; Male; Organ Size; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testis | 1989 |
Induction of metachromasia in experimentally induced hyperplastic/hypertrophic changes in the prostate of the cynomolgus monkey (Macaca fascicularis).
Topics: Androstenedione; Animals; Aromatase Inhibitors; Macaca fascicularis; Male; Prostate; Prostatic Hyperplasia; Staining and Labeling | 1989 |
Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Female; Humans; Luteinizing Hormone; Male; Mammary Neoplasms, Experimental; Microsomes; Orchiectomy; Ovary; Pargyline; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Reference Values | 1989 |
Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Fadrozole; Female; Imidazoles; Mammary Neoplasms, Experimental; Nitriles; Rats; Rats, Inbred Strains | 1989 |
5 alpha-reductase activity in epithelium and stroma of prostates from intact and castrated dogs treated with androstenedione, the aromatase inhibitor 1-methyl-1,4-androstadiene-3,17-dione, and cyproterone acetate.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Aromatase Inhibitors; Cyproterone; Cyproterone Acetate; Drug Interactions; Epithelium; Kinetics; Male; Orchiectomy; Prostate | 1988 |
Aromatase-inhibitors of the androstenedione-type activate the 17 beta-hydroxysteroid-dehydrogenase in the rat testis tissue suspension model.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Aromatase Inhibitors; Culture Techniques; Dihydrotestosterone; Enzyme Activation; Male; Rats; Structure-Activity Relationship; Testis; Testosterone | 1988 |
Effect of aromatase inhibitors on the functional morphology of the pituitary gland of dogs and monkeys.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Cyproterone; Dogs; Macaca fascicularis; Male; Organ Size; Pituitary Gland; Pituitary Hormones; Rats; Reference Values; Species Specificity; Testis | 1988 |
1-Methyl-1,4-androstadiene-3,17-dione (SH 489): characterization of an irreversible inhibitor of estrogen biosynthesis.
Topics: Androstenedione; Aromatase Inhibitors; Female; Humans; In Vitro Techniques; Kinetics; Microsomes; Oxidation-Reduction; Placenta; Pregnancy; Structure-Activity Relationship | 1986 |
[Aromatase inhibitors in the medical treatment of benign prostatic hypertrophy].
Topics: Androstenedione; Aromatase Inhibitors; Humans; Male; Prostatic Hyperplasia | 1993 |
Medical therapy for benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Androstenedione; Aromatase Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Hyperplasia | 1995 |
Effects of estrogen deprivation on human benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Androstenedione; Aromatase Inhibitors; Estradiol; Estrone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia | 1993 |
In vitro studies on the inhibition of testosterone synthesis in the human testis by atamestane.
Topics: 17-Hydroxysteroid Dehydrogenases; Aged; Androstenedione; Binding, Competitive; Humans; In Vitro Techniques; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testis; Testosterone | 1993 |
Further evidence of increased aromatase activity in granulosa luteal cells from polycystic ovary.
Topics: Adult; Androstenedione; Aromatase; Aromatase Inhibitors; Cell Count; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Granulosa Cells; Humans; Insulin; Kinetics; Luteal Cells; Polycystic Ovary Syndrome; Progesterone | 1997 |
Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells.
Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Carcinoma, Hepatocellular; Choriocarcinoma; Colforsin; Cycloheximide; Enzyme-Linked Immunosorbent Assay; Fadrozole; Humans; Liver Neoplasms; Neoplasm Proteins; Protein Synthesis Inhibitors; RNA, Messenger; Triazoles; Tumor Cells, Cultured | 1998 |
Characterization of aromatase cytochrome P450 activity in the human temporal lobe.
Topics: Adolescent; Adult; Age Factors; Androstenedione; Aromatase; Azasteroids; Child; Dose-Response Relationship, Drug; Female; Finasteride; Humans; Kinetics; Male; Middle Aged; Organ Specificity; Placenta; Sex Factors; Temporal Lobe | 1999 |
The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model.
Topics: Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Disease Models, Animal; Female; Humans; Letrozole; Lipids; Models, Chemical; Nitriles; Organ Size; Ovariectomy; Rats; Rats, Sprague-Dawley; Toremifene; Triazoles; Uterus | 2007 |
Toremifene-atamestane; alone or in combination: predictions from the preclinical intratumoral aromatase model.
Topics: Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, SCID; Prognosis; Toremifene; Transfection; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
Comparing the effects of atamestane, toremifene and tamoxifen alone and in combination, on bone, serum lipids and uterus in ovariectomized rats.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Body Weight; Bone Density; Bone Density Conservation Agents; Clinical Trials as Topic; Compressive Strength; Epithelial Cells; Estrogen Antagonists; Female; Femur; Humans; Lipids; Lumbar Vertebrae; Ovariectomy; Rats; Rats, Sprague-Dawley; Stress, Mechanical; Tamoxifen; Toremifene; Uterus | 2009 |